Recent progress in research on narcotic antagonists.
D000818:Animals; D001575:Benzomorphans / Q000031:analogs & derivatives / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D003496:Cyclazocine / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008954:Models, Biological; D009019:Morphinans / Q000494:pharmacology; D009022:Morphine Derivatives / Q000494:pharmacology; D009266:Nalbuphine / Q000031:analogs & derivatives / Q000627:therapeutic use; D009270:Naloxone / Q000378:metabolism; D009271:Naltrexone / Q000378:metabolism; D009292:Narcotic Antagonists / Q000138:chemical synthesis / Q000494:pharmacology; D009294:Narcotics; D010423:Pentazocine / Q000378:metabolism / Q000627:therapeutic use; D011957:Receptors, Opioid / Q000378:metabolism; D013329:Structure-Activity Relationship; D019966:Substance-Related Disorders / Q000534:rehabilitation; D013797:Thebaine / Q000031:analogs & derivatives / Q000494:pharmacology
D001575:Benzomorphans; D009019:Morphinans; D009022:Morphine Derivatives; D009292:Narcotic Antagonists; D009294:Narcotics; D011957:Receptors, Opioid; D013797:Thebaine; D009270:Naloxone; D009271:Naltrexone; D003496:Cyclazocine; D009266:Nalbuphine; D010423:Pentazocine